By the Kaplan-Meier plotter, a higher BTG1 expression was negatively correlated with overall and progression-free survival rates of all cancer patients, male or perforating cancer patients and patients receiving 5-FU-based adjuvant (Figure 1F; Table 1, p < 0.05). The gene discussed is BTG1; the disease is cancer.